Searching:
Search by keyword, patent number, inventor, assignee, city or state:
| Patent # | Description |
|---|---|
| US-5,409,951 |
Fungicidally active compounds Novel compounds of formula I ##STR1## wherein R.sup.1 is independently hydrogen, hydroxy, alkyl with 1 to 6 carbon atoms, acyloxy groups with 1 to 6 carbon... |
| US-5,409,950 |
Cyclic ketal derivatives Compounds are described of the formula ##STR1## wherein R.sub.1 represents a hydrogen atom, a hydroxyl group or a group selected from... |
| US-5,409,949 |
Methylen-oxindole derivatives compositions and tyrosine kinase
inhibition therewith The invention provides new methylen-indole derivatives of formula (I) ##STR1## wherein R is a group ##STR2## in which R.sub.4 is hydrogen, hydroxy,... |
| US-5,409,948 |
Method for treating cognitive disorders with phenserine An improved method of cholinomimetic therapy for cognitive impairments associated with aging and Alzheimer's disease comprising treating a patient with an... |
| US-5,409,947 |
Cycloheptimidazole derivatives, method of manufacturing the same and
therapeutic agents containing these compounds New therapeutic agents of cycloheptimidazole derivatives are disclosed, which are represented by the following formula or its alkali-addition salts. ... |
| US-5,409,946 |
Isoxazole, isothiazole and pyrazole compounds that enhance cognitive
function Novel isoxazole isothiazole and pyrazole compounds of the formula: ##STR1## wherein A, R.sup.1, and R.sup.2 are specifically defined, or pharmaceutical... |
| US-5,409,945 |
Benzyo-fused thiazolidinyl terminated alkylamino ethylnyl alanine amino
diol compounds for treatment of... Compounds characterized generally as benzo-fused thiazolidinyl-terminated alkylamino ethynyl alanine amino diol derivatives are useful as renin inhibitors for... |
| US-5,409,944 |
Alkanesulfonamido-1-indanone derivatives as inhibitors of cyclooxygenase Disclosed are compounds of Formula I useful in the treatment of cyclooxygenase mediated diseases such as pain, fever and inflammation of a variety of conditions... |
| US-5,409,943 |
[(alkoxy)pyridinyl]amine compounds which are useful in the treatment of
gastrointestinal disorders The present invention relates to N-pyridylamidine and N-pyridylguanidine derivatives of general formula (I) in which: Ar.sup.1 is an optionally substituted... |
| US-5,409,942 |
Calcium uptake inhibitors This invention relates to 1-phenyl-3-aryl-2-propyne-1-ones, the use of these compounds as calcium uptake inhibitors in leukocytes and thrombocytes, and... |
| US-5,409,941 |
5-heteroyl indole derivatives Compounds of the formula ##STR1## which are useful in treating migraine and other disorders, and intermediates used in the preparation of said compounds. |
| US-5,409,940 |
3,4-dehydropiperidine derivatives The invention relates to a group of new 3,4-dehydropiperidine derivatives of the formula ##STR1## wherein R.sub.1 is a hydrogen atom or an alkyl group... |
| US-5,409,939 |
Phenyl amidine thio derivatives useful as platelet aggregation inhibitors This invention relates to compounds having the following formula ##STR1## which are useful in the inhibition of platelet aggregation. This invention also... |
| US-5,409,938 |
Antimalarial korupensamines and pharmaceutical compositions and medical
uses thereof The present invention provides new antimalarial compounds called korupensamines, korupensamine derivatives, and pharmacologically acceptable salts thereof,... |
| US-5,409,937 |
Hexahydrofuro(2,3-b)furans as PAF antagonists The invention concerns compounds of the formula I: ##STR1## wherein the variables are described in the specification which are antagonists of platelet... |
| US-5,409,936 |
Imidazopyridine derivatives for the treatment of hypertension An imidazopyridine derivative is disclosed of the formula [I]: ##STR1## wherein R.sup.1 is lower alkyl, R.sup.2 is a group of the formula ##STR2## ... |
| US-5,409,935 |
Xanthine derivatives for the treatment of secondary nerve cell damage
and functional disorders after... The use of xanthine derivatives for the treatment of secondary nerve cell damage and functional disorders after cranio-cerebral traumas (CCT) The use of xanthine... |
| US-5,409,934 |
Xanthine derivatives |
| US-5,409,933 |
Quinoline derivatives and processes for preparing the same The present invention relates to novel quinoline derivatives of formula (I): ##STR1## wherein R.sub.1, R.sub.2, R.sub.3, X, Y and Z are defined as in the ... |
| US-5,409,932 |
Piperazine-substituted pyrroloanthracenes The piperazine-substituted pyrroloanthracenes are prepared by reacting either furanoanthracenes with piperazinalkylamines or reacting unsubstituted... |
| US-5,409,931 |
1,3-substituted cycloalkenes and cycloalkanes as central nervous system
agents 1,3-Substituted cycloalkenes and cycloalkanes are described, as well as methods for the preparation and pharmaceutical composition of same, which are useful as... |
| US-5,409,930 |
Bis mono- and bicyclic aryl and heteroaryl compounds which inhibit EGF
and/or PDGF receptor tyrosine kinase This invention relates to bis mono- and/or bicyclic aryl and/or heteroaryl compounds exhibiting protein tyrosine kinase inhibition activity. More specifically,... |
| US-5,409,929 |
Hydroisoindolines and hydroisoquinolines as psychotropic drugs There are provided novel nitrogen-containing bicyclic compounds which are useful in the treatment of physiological or drug induced psychosis or dyskinesia in a... |
| US-5,409,928 |
Condensed pyrazole derivatives, method of manufacturing the same, and
androgen inhibitor This invention provides a condensed pyrazole derivative of the Formula (1): ##STR1## (where A denotes CH or N, R.sup.0 and R.sup.3 denote same or different, a ... |
| US-5,409,927 |
Morpholin- and thiomorpholin-4-ylamides There are described compounds of formula I ##STR1## wherein R.sub.1 is hydrogen or lower alkyl, R.sub.2 is hydrogen, lower alkyl, lower alkoxycarbonyl, phenyl-... |
| US-5,409,926 |
AT-2 antagonist inhibition of vascular restenosis Novel disubstituted 6-aminoquinazolinones of the Formula ##STR1## are useful as angiotensin-II receptor (subtype 2) antagonists (AT.sub.2 antagonists) alone... |
| US-5,409,925 |
Oxazobicyclo terminated alkylamino ethynyl alanine amino diol compounds
for treatment of hypertension Compounds characterized generally as oxazobicyclo-terminated alkylamino ethynyl alanine amino diol derivatives hypertension. Compounds of particular interest are... |
| US-5,409,924 |
Benzo-fused oxazobicyclo terminated alkylamino ethynyl alanine amino
diol compounds for treatment of hypertension Compounds characterized generally as benzo-fused oxazobicyclo-terminated alkylamino ethynyl alanine amino diol derivatives are useful as renin inhibitors for the... |
| US-5,409,922 |
Thiozopinyl terminated alkylamino ethynyl alanine amino diol compounds
for treatment of hypertension Compounds characterized generally as thiazopinyl-terminated alkylamino ethynyl alanine amino diol derivatives are useful as renin inhibitors for the treatment of... |
| US-5,409,921 |
Thiazetidinyl-terminated alkylamino ethynyl alanine amino diol compounds
for treatment of hypertension Compounds characterized generally as thiazetidinyl-terminated alkylamino ethynyl alanine amino diol derivatives are useful as renin inhibitors for the treatment... |
| US-5,409,920 |
2-(3-pyridyl)-carbapenem antibacterial agents Carbapenems of the formula ##STR1## are useful antibacterial agents. |
| US-5,409,919 |
Pharmaceutically acceptable salt of
7B-[2-(5-amino-1,2,4-thio-diazol-3-yl)-2(Z)-metho-xyiminoacetamido]-3-[(
... A compound of the formula: ##STR1## wherein R.sup.1 is an amino group which may be protected, R.sup.3 is a hydrogen atom or an optionally substituted... |
| US-5,409,918 |
Crystalline cephem acid addition salts and process for their preparation Crystalline cephem acid addition salts of the general formula II ##STR1## pharmaceutical preparations effective against bacterial infections which contain... |
| US-5,409,917 |
Topical treatment of acne with cephalosporins A method and composition for topically treating acne and acneiform dermal disorders includes applying an amount of a cephalosporin antibiotic effective to treat... |
| US-5,409,916 |
Fiber reactive anthraquinone dyes Fiber reactive dyes of the anthraquinone type which provide brilliant violet colors without metal complexing. These dyes may be represented by the formula: ... |
| US-5,409,915 |
Bis-platinum (IV) complexes as chemotherapeutic agents Novel bis(platinum) (IV) complexes coupled via diamine bridging agents are taught as well as methods for their preparation. These complexes are to be used as... |
| US-5,409,914 |
Metallo-organic cobalt compounds and uses thereof The present invention provides a pharmaceutical composition of a complex compound having the structure: ##STR1## wherein R.sub.1 and R.sub.1, are the same... |
| US-5,409,913 |
Oxazocinyl/thiazocinyl terminated alkylamino ethynyl alanine amino diol
compounds for treatment of hypertension Compounds characterized generally as oxazocinyl/thiazocinyl-terminated alkylamino ethynyl alanine amino diol derivatives are useful as renin inhibitors for the... |
| US-5,409,912 |
Leustroducsin H, its preparation and its therapeutic use A new compound, which we have named Leustroducsin H, has formula (I): ##STR1## and pharmaceutically acceptable salts thereof. This compound may be prepared... |
| US-5,409,911 |
Prostaglandin analog for treating osteoporosis This invention relates to a prostaglandin-bisphosphonate compound of the formula: ##STR1## and its pharmaceutically acceptable salts. The claimed compounds... |
| US-5,409,910 |
Substituted pyridines New substituted pyridines are prepared by reducing suitably substituted pyridine derivatives. The new substituted pyridines are suitable as active compounds in... |
| US-5,409,909 |
1,4-diazepine derivative and its pharmaceutical use A triazolo-1,4-di-azepine compound of the below given formula and a pharmacologically acceptable salt thereof are disclosed and useful in the pharmaceutical... |
| US-5,409,908 |
Complexing urushiols This invention relates to use of cyclodextrins to complex urushiols to protect against and to treat irritation arising from exposure to urushiols. Cyclodextrins,... |
| US-5,409,907 |
Aqueous pharmaceutical suspension for pharmaceutical actives The present invention relates to an aqueous pharmaceutical suspension composition comprising: from about 0.2% to 20% of a substantially water soluble... |
| US-5,409,906 |
.alpha. nucleoside compounds and a method for treating HBV using said
compounds A compound of the formula ##STR1## wherein the radicals A, X, R.sup.1, R.sup.2 and R.sup.3 are defined as follows: A: ##STR2## X: (a) O (b) S ... |
| US-5,409,905 |
Cure for commond cold Present invention is a non-toxic, flavor stable, pleasant tasting composition releasing Zn.sup.2+ from compositions containing a highly ionizable zinc compound... |
| US-5,409,904 |
Hyaluronic acid compositions and methods Disclosed are solutions useful in surgery comprising a viscous or viscoelastic substance in an aqueous vehicle which is characterized as physiologically... |
| US-5,409,903 |
Method and compositions for the treatment of H. pylori and dermatitis A method of treating a mammal for the presence or the activity of H. pylori in the gastrointestinal tract is disclosed. The method encompasses orally ... |
| US-5,409,902 |
Oral hygiene compositions containing glyceroglycolipids as antiplaque
compounds Oral hygiene antiplaque compositions which include as an active ingredient a glyceroglycolipid having an amine or ether linkage and containing a ... |
| US-5,409,901 |
Therapeutic compositions comprising nucleoproteins as the active agents,
and methods of producing and using... The present invention relates to the production of nucleoproteins, more especially DNA, and their use in therapeutic compositions suitable for the treatment of... |
Copyright 2008−2012 Patents.com
